Biotechnology Stocks Pre-Market Movers

Gainers • Immunogen, Inc. (NASDAQ:IMGN) shares rose 21.1% to $6.49 during Friday's pre-market session. • Inovio Pharmaceuticals, Inc. (NASDAQ:INO) stock rose 14.0% to $4.40. The most recent rating by PiperJaffray, on January 03, is at Overweight, with a price target of $8.00. •...

Gainers • Cleveland BioLabs, Inc. (NASDAQ:CBLI) stock surged 22.8% to $2.48 during Thursday's pre-market session. • Soligenix, Inc. (NASDAQ:SNGX) shares increased by 10.7% to $2.90. • Vaxart, Inc. (NASDAQ:VXRT) shares rose 8.5% to $1.15. • Inovio Pharmaceuticals, Inc. (...

Gainers • Titan Pharmaceuticals, Inc. (NASDAQ:TTNP) stock moved upwards by 31.6% to $0.30 during Wednesday's pre-market session. • Aclaris Therapeutics, Inc. (NASDAQ:ACRS) shares rose 5.1% to $1.44. • ADMA Biologics, Inc. (NASDAQ:ADMA) shares increased by 4.3% to $3.74. •...

Gainers • Rexahn Pharmaceuticals, Inc. (NASDAQ:REXN) stock moved upwards by 34.1% to $2.75 during Tuesday's pre-market session. • Onconova Therapeutics, Inc. (NASDAQ:ONTX) shares surged 8.5% to $0.65. • MorphoSys, Inc. (NASDAQ:MOR) stock moved upwards by 3.5% to $31.47. According...

Gainers • vTv Therapeutics, Inc. (NASDAQ:VTVT) shares rose 71.9% to $3.61 during Monday's pre-market session. • Mereo BioPharma Group, Inc. (NASDAQ:MREO) shares increased by 27.4% to $2.00. • Adverum Biotechnologies, Inc. (NASDAQ:ADVM) shares moved upwards by 17.2% to $12.00. The...

Gainers • Seelos Therapeutics, Inc. (NASDAQ:SEEL) shares moved upwards by 12.2% to $1.01 during Friday's pre-market session. The most recent rating by H.C. Wainwright, on November 18, is at Buy, with a price target of $2.00. • Catalyst Biosciences, Inc. (NASDAQ:CBIO) shares surged 10....

Gainers • Aquestive Therapeutics, Inc. (NASDAQ:AQST) shares rose 9.2% to $4.39 during Thursday's pre-market session. The most recent rating by BMO Capital, on January 13, is at Outperform, with a price target of $18.00. • BioNTech, Inc. (NASDAQ:BNTX) shares rose 8.8% to $31.83. The...

Gainers • Galapagos, Inc. (NASDAQ:GLPG) stock surged 5.5% to $243.43 during Tuesday's pre-market session. According to the most recent rating by JP Morgan, on January 06, the current rating is at Neutral. • DBV Technologies, Inc. (NASDAQ:DBVT) stock surged 3.4% to $10.17. The most...

Gainers • Aimmune Therapeutics, Inc. (NASDAQ:AIMT) shares increased by 15.5% to $35.87 during Monday's pre-market session. The most recent rating by Cantor Fitzgerald, on February 03, is at Overweight, with a price target of $64.00. • Cocrystal Pharma, Inc. (NASDAQ:COCP) shares...

Gainers • Cleveland BioLabs, Inc. (NASDAQ:CBLI) stock rose 18.4% to $3.73 during Friday's pre-market session. • Reata Pharmaceuticals, Inc. (NASDAQ:RETA) shares surged 5.9% to $205.50. The most recent rating by Cantor Fitzgerald, on November 20, is at Overweight, with a price target...

Gainers • Miragen Therapeutics, Inc. (NASDAQ:MGEN) stock surged 63.9% to $2.77 during Thursday's pre-market session. The most recent rating by Baird, on December 12, is at Neutral, with a price target of $1.00. • Novus Therapeutics, Inc. (NASDAQ:NVUS) shares rose 33.3% to $0.80. The...

Gainers • Hepion Pharmaceuticals, Inc. (NASDAQ:HEPA) shares increased by 34.7% to $6.71 during Wednesday's pre-market session. The most recent rating by Brookline Capital, on November 22, is at Buy, with a price target of $12.00. • Conatus Pharmaceuticals, Inc. (NASDAQ:CNAT) shares...

Gainers • Acceleron Pharma, Inc. (NASDAQ:XLRN) stock moved upwards by 59.8% to $84.49 during Tuesday's pre-market session. The most recent rating by Citigroup, on January 22, is at Buy, with a price target of $75.00. • Vaxart, Inc. (NASDAQ:VXRT) stock rose 34.9% to $0.87. •...

Gainers • Inovio Pharmaceuticals, Inc. (NASDAQ:INO) shares moved upwards by 28.8% to $5.46 during Monday's pre-market session. The most recent rating by PiperJaffray, on January 03, is at Overweight, with a price target of $8.00. • Cleveland BioLabs, Inc. (NASDAQ:CBLI) stock rose 21.2...

Gainers • Tonix Pharmaceuticals, Inc. (NASDAQ:TNXP) stock moved upwards by 33.8% to $1.86 during Friday's pre-market session. • Inovio Pharmaceuticals, Inc. (NASDAQ:INO) shares increased by 10.7% to $4.25. The most recent rating by PiperJaffray, on January 03, is at Overweight, with a...